Related by context. All words. (Click for frequent words.) 58 vol.# 57 Suppl. 57 Supplemental Figure 56 L# L# [002] 56 #.# [042] 56 Eur Urol 56 suppl. 56 Suppl 55 Nat Genet 55 Ptf 55 :# [002] 55 Arch Dermatol 55 rev. 55 See id 55 #:#-# [014] 54 MB Docket 54 CFR #.# c 54 Opp'n 54 Pl. s 54 Eq. 54 CD# [004] 54 :9 54 NJAC 6A 54 #:#-# [037] 54 Def. s 54 NJSA 2C :5 54 TCA § #-#-# [003] 54 § #E 54 pp.# [002] 54 scs 54 Arch Neurol 53 doi doi 53 § § #-# [003] 53 #:#-# [002] 53 OGJ Mar. 53 cmt 53 #a #a [002] 53 :2 53 suppl 53 NJSA 2C :2 53 :4 53 abstr 53 Contracts § 53 Vacancy Announcement 53 Vol.# [001] 53 Biol 53 doi #.# 53 Ann Emerg Med 53 #.#-# b [002] 53 Neurol 53 Exh 53 #.#/journal.pmed.# 53 Docket Number 53 Sec.# [002] 53 Abstract Full Text 52 Dent Res 52 #:#-# [029] 52 DOI #.#/S#-# 52 Environ Health Perspect 52 op cit 52 Ann Intern Med 52 J Pediatr 52 #.#-# [006] 52 #:#-# [033] 52 :5 52 vol. 52 :7 52 See ARS § 52 NWLR PT 52 #:#-# [020] 52 #.#-# b [001] 52 ISSN #-# 52 :# [004] 52 para. 52 :# [003] 52 § #.# [002] 52 Pharmacol 52 USC § #a b 52 See Restatement Second 52 Crit Care 51 NWLR pt 51 #d# [001] 51 p.2 51 e# [005] 51 Ont. SCJ 51 vide Notification 51 Eur J Cancer 51 Concluding Remarks 51 Reproduced Record RR 51 Article ChemPort 51 Vol.# No.# 51 Schizophr Bull 51 ISBN 0 51 :3 51 Supplementary Table 51 Obes Res 51 Va. Code § 51 Struct 51 pp.# [001] 51 FOF ¶ 51 ref. 51 GRA# 51 dated #.#.# [002] 51 #.# [023] 51 #:# [013] 51 #S #S [003] 51 USC #a [001] 51 C# [002] 51 Calgary AB T2P 51 CI# [002] 51 Neurobiol 51 § #-#-# b [003] 51 art. 51 R.# [001] 51 Toxicol 51 Erratum 51 Docket # 51 #:#-# [016] 51 Neurosci 51 p8 50 NJSA #A 50 Oncol 50 Judgments § 50 Doc. No. 50 USC § § #e 50 Legal #.# 50 J Urol 50 n.# [001] 50 CFR § #.# [006] 50 Cancer Res 50 Curr Opin 50 Income Tax Regs 50 Ibid 50 e# e# [003] 50 Figs. 50 Rheumatol 50 ,#,# [002] 50 #:#-# [031] 50 vide Notification No. 50 Ann Oncol 50 Nat Med 50 vide notification 50 Mol Psychiatry 50 #F [005] 50 #-#-# [011] 50 pp# [001] 50 #S #S [002] 50 Nat Biotechnol 50 J Am Soc 50 Proc Am 50 Chp 50 #.#.#.# [011] 50 Vol.# [002] 50 #a# [003] 50 :1 50 Clin Oncol 50 doi #.#/S#-# 50 Biotechnol 50 Dkt. No. 50 J Clin Oncol 50 NWLR Part 50 e# [001] 50 Anesth 50 Mol Med 50 Dermatol 50 RNS Number 50 #S #S [001] 50 Physiol 50 Psychosom Med 50 #:#-# [025] 50 Antiviral Therapy 50 Br J Dermatol 50 Id. § 49 USC § #a [001] 49 WpHG mit dem Ziel 49 #:#-# [027] 49 WL # SDNY [001] 49 κ 49 Mol Biol 49 ¼ l 49 49 Am J Epidemiol 49 doi #.#/journal.pone.# 49 Pv 49 #O [002] 49 Marion Bartoli FRA 49 Defs. 49 B.1 49 J Infect Dis 49 s.# [001] 49 NUREG 49 Ruhel Chisty MRACI 49 Physica 49 p4 49 FASEB J 49 #.# subd [004] 49 J Natl Cancer Inst 49 Fed. 49 Mol Cell 49 Eur Respir J 49 PS § § 49 Lancet Oncol 49 Analogues 49 Gynecol Oncol 49 ATTACHMENT 49 #.#A [005] 49 guanylyl cyclase 49 #.pdf [001] 49 pp #-# 49 Pricing Supplement 49 Cell Biol 49 cmp 49 Br J Clin Pharmacol 49 Clin Endocrinol 49 Arch Pediatr Adolesc Med 49 p.3 49 Pract 49 Consultation Document 49 ASCO Abstract 49 #a #a [001] 49 dated #.#.# [001] 49 www.piperalderman.com.au 49 Pathol 49 § § #-#-# [001] 49 Supplementary Figs 49 Schematic representation 49 J Affect Disord 49 NIH Publication 49 Docket Entry No. 49 Pl. 49 Ord. 49 Hypertens 49 mso ansi language 49 + sizeof 49 B# [004] 49 #-#.#.# [001] 49 antitrypsin 49 Eur Heart 49 Obstet Gynecol 49 #-# Full Text 49 G# [003] 49 SDNY Mar. 49 ChemPort 49 CrossRef Medline 49 Article PubMed 49 J Clin 49 NOTIFICATION OF MAJOR INTERESTS 49 USC § #u 49 Pp 49 NJSA #:# [002] 49 Int Clin Psychopharmacol 49 Microbiol 49 CFR § #.# [003] 49 D# [004] 49 #:#-# [019] 49 USC § #b [002] 49 p.8 49 Propagation Forecast Bulletin 49 Red Hat alert RHSA 49 Semester Examination 48 Dkt. 48 § #.# [004] 48 Free Full Text 48 J Appl 48 J Clin Psychiatry 48 Pediatr 48 ErP 48 #a #a [003] 48 Practice Direction 48 ZAE # 48 Rehabil 48 FASEB J. 48 Nucleic Acids Res 48 function var = 48 memset 48 #a# [001] 48 deoxy 48 Rev. Lett 48 PLoS Genet 48 #:#-# [018] 48 ¾ l 48 No.#/# [001] 48 Psychol 48 #:#-# [008] 48 #/Aug 48 Guidance Document 48 #-# [006] 48 Biophys 48 #:#-# [023] 48 integrin alpha 48 p1 48 np 48 NJSA #:# [001] 48 OJ C# 48 TVID 48 pp. #-# [006] 48 Appendix 3B Page 48 CFR #.# [001] 48 Urol 48 DC Code § 48 ASX Announcement 48 NNNN 48 J Nerv Ment Dis 48 VARIO 48 dated #-#-# [002] 48 mso fareast language 48 Apolipoprotein 48 Grd 48 DOI #.# 48 CODE § 48 Abstract Number 48 Ann Rheum Dis 48 Cv 48 #-# [053] 48 #-# #-# [013] 48 #:#-# [001] 48 p.# [001] 48 6e 48 Annexes 48 USC § #a c 48 Ann Pharmacother 48 CFR #.# b 48 Annexin 48 -2 -3 48 annexed hereto 48 Def. 48 S# S# [001] 48 J Clin Endocrinol Metab 48 #:#-# [021] 48 4e 48 § #a [002] 48 #.#-# [005] 48 Bankr. EDNC 48 PO4 48 CFR § #.# [008] 48 Expert Opin 48 Child Adolesc Psychiatry 48 END FOOTNOTE FOOTNOTE 48 w# w# 48 PLoS Biol 48 fig. S3 48 Int J Epidemiol 48 #-#.# [016] 48 doc. # 48 Cropredy Res 48 #,# bis 48 cid = 48 Article ISI ChemPort 48 CFR #.#b 48 #-#/#L #/#L 48 #:#-# [022] 48 VGS = 48 Rel. 48 Osteoporos Int 48 supra § 48 Proc Natl Acad Sci 48 Ohio Adm.Code 47 mH 47 Onc 47 - -Crazyhorse 47 #G# [002] 47 Vernon Supp 47 F# [003] 47 NB. 47 LSA RS #:# [002] 47 C.1 47 doi #.#/nature# 47 Dkt 47 Ostomy Wound Management 47 #.#-# [027] 47 Biol Psychiatry 47 p.1 47 EFFECTIVE DATE 47 c.# [001] 47 DFARS #.#-# 47 sid = 47 See USSG 47 § #:# [001] 47 #.pdf [002] 47 = sizeof 47 & Ors 47 N# [005] 47 P#S 47 #-# [027] 47 Med Assoc 47 L imited 47 J Psychopharmacol 47 jrw 47 Physics Letters 47 Am Fam Physician 47 #:#-# [028] 47 #.# 5T 47 B.2 47 Br J Cancer 47 Article PubMed ChemPort 47 J Nutr 47 Nat Rev Neurosci 47 #:#-# [006] 47 NCGS § 47 Repl. 47 PMID # [002] 47 CFR § #.# [007] 47 NYCRR #.# [003] 47 EN1 47 Fig. 1a 47 #.#-# [001] 47 USC #d 47 CFR § § #.# [001] 47 = null 47 Pet'r 47 J. Appl 47 Appendix 1A 47 #-#-# [070] 47 EXPLANATORY MEMORANDUM 47 § #A [001] 47 LANCET 47 S1 S# [001] 47 § § #-#-# [002] 47 Nucl Med 47 HT 1A 47 J Biol Chem 47 # Köln 47 #C# [002] 47 hd #-#/#L 47 #/#/EC [001] 47 EXECUTIVE SUMMARY 47 p.9 47 Arch Intern Med 47 J Child Adolesc 47 C.# 47 Thromb Haemost 47 Clin Infect Dis 47 ¾ l nk 47 unsigned char 47 #:#-# [035] 47 Figure S4 47 ev enthusiast # 47 EMBO J. 47 Clin Psychol Rev 47 Acid Digestion 47 patrick.graham @ thomson.com 47 J Fam Pract 47 WF2 47 IECQ 47 Directive #/#/EU 47 Int J 47 #.#.#R 47 BJ# 47 Règlement 47 2DR 47 USC § #a [003] 47 p.4 47 Endocrinol Metab 47 Ann Surg 47 Neurosurg 47 Psychopharmacol Bull 47 2XX 47 MC# [001] 47 Arch Facial Plast 47 Eur J 47 Supp. 47 Brain Res 47 Docket Entry 47 Br J 47 # XN 47 proce 47 #:# -# [001] 47 Am J Cardiol 46 Clinical Nutrition Vol. 46 #A NCAC 46 Bulk Ex Kandla 46 mso bidi language 46 Rs.# w 46 Ltr 46 M.# 46 #.html [002] 46 Psychiatr Serv 46 § #-#-# c [001] 46 2n 46 #-#.# [017] 46 Sciencexpress 46 Sports Exerc 46 spud #-#-# drlg [003] 46 N0 46 #d [002] 46 Content Outline 46 2Z 46 ESMO Accepted Abstract 46 #:# Distr 46 Puls Biznesu pp. 46 ND Tex. 46 ibid 46 Add.1 46 cx 46 doi #.#/fj.#-# 46 J Exp Med 46 #/#/EC [002] 46 Psychiatry Res 46 Nat Clin Pract 46 LEXIS 46 FERC Stats 46 Evid 46 Art. 46 MT GRAVATT 46 Certifications Commercial 46 Histologic 46 #bis 46 quoting Restatement Second 46 % #.pdf 46 J Clin Psychopharmacol 46 beta tubulin 46 Nephrol 46 ETSI TS 46 ained 46 Br J Haematol 46 7r 46 Cf 46 #ff [001] 46 hugin.info/#/R/#/#.pdf [001] 46 Exs 46 Posted #/#/# [002] 46 Nature doi #.#/nature# 46 WT Docket No. 46 carboxypeptidase 46 #-#-# [071] 46 H# [004] 46 USC § #c 46 #,#-# [008] 46 Cochrane Database Syst Rev. 46 Resp't 46 R.# [002] 46 Fig. 4c 46 § 7B 46 Gazeta Wyborcza pp. 46 Pub. 46 § #-#.# [001] 46 yl 46 2d ed 46 DOI #.#/j.#-#.#.#.x 46 Colo. Sess 46 A#V 46 DOI #.#/nature# 46 #T# [005] 46 HRS § 46 charset = 46 #.# [041] 46 TEXT OMITTED FROM SOURCE 46 I.1 46 в 46 CURR 46 Conforms 46 CFR § #.# [002] 46 5F 46 8w 46 Docket Nos. 46 sh hd 46 Pressure Transducer 46 Addict Behav 46 contravenes Article 46 Cn 46 J Virol 46 AR3 46 Oral Session 46 fig. 46 #-#-# [026] 46 Cleator MC 46 Symp 46 gadolinium enhancing 46 UNI XC 46 #B.# [002] 46 iii iv 46 Am J Gastroenterol 46 ANSI AAMI 46 MoxDuo R 46 hcp #-# [001] 46 Tr. 46 bdr 46 CFR #.# [002] 46 Diabet Med 46 Abstract Free Full Text 46 #,# dimethyl 46 Consultation Paper 46 Prostaglandin 46 #,# OH 46 #ff [002] 46 L.#/# 46 #-#/#L #-#/#L 46 http:/hugin.info/#/R/#/#.pdf [001] 46 Cardiol 46 dated #.#.# [003] 46 phospholipase 46 No.#/# [003] 46 #o [002] 46 constitutively active 46 Slaithwaite CBC 46 CFR § #.# [004] 46 Clin Cancer 46 #:# [008] 46 Int J Cancer 46 footnote omitted 46 Microstructure 46 #,#,#,# [006] 46 drlg 46 I# I# [002] 46 Soc Sci Med 46 CFR #.# [005] 46 B.3 46 Comp. 46 # [008] 46 Vc 46 Int J Radiat Oncol 46 pgs 46 Bioorganic 46 # NNNN 46 = argv 46 Phytochemistry 46 d BSHS 46 -#-# [004] 46 1L #-#/#L 46 QBD 46 Fig. 3d 46 END FOOTNOTE 46 J# [001] 46 #/#L #/#L 46 Kidney Int 46 t6 46 Endnotes 46 Pa. Code § 46 USSG § #B#.# [002] 46 WL # [002] 46 Numerical Methods 46 χ 46 Rzeczpospolita pp. A1 46 Hematol 46 Intensive Care Med 46 #b [002] 45 -Genereaux 45 с 45 Appx 45 = NULL [002] 45 :0 45 J Clin Epidemiol 45 #.#E [002] 45 Infect Dis 45 s. 45 3d ed 45 no.# [001] 45 W6M 45 www.dti.gov.uk 45 suppl #S 45 pyridyl 45 #CCC 45 Epidemiol 45 Robin Soderling SWE 45 § #.#.# [002] 45 -# [007] 45 ASX Announcements 45 BAST 45 Cricklade Tn 45 vide SRO 45 NJSA 2A #A 45 minor op.# 45 PARAGRAPH 45 Hr'g Tr 45 Acta Psychiatrica Scandinavica 45 JBJS 45 EndoTAG ® 45 Pg. 45 -Sen. Larcenia Bullard 45 3AB 45 § #-#-# [004] 45 SO4 45 AQUARIUS PLATINUM LIMITED 45 CFR #.# [006] 45 CUSIP Nos. # 45 C.3 45 #,#,#,# [001] 45 Resp 45 G# [005] 45 Br J Psychiatry 45 GATT Article 45 pawel.sobczak @ thomson.com 45 Interval m 45 #:#-# [030] 45 #/#/EEC [002] 45 Y Y -#.# 45 NJAC #:#-#.# 45 LSA RS #:# [001] 45 :8 45 Legislative Decree 45 ML# [003] 45 RU EUROPE EEU ASIA 45 Symbol Rate 45 § #-#-# [001] 45 Applicability 45 NDTV HINDU NIGHT VISION 45 Schizophrenia Bulletin 45 1e 45 microg 45 WPHG 45 p.5 45 Cell Physiol 45 ICAO Annex 45 Disord 45 border="0"> 45 DOI #.#/science.# 45 doc. 45 COLLIER ON 45 Am J Pathol 45 #a [003] 45 END FOOTNOTE * 45 Figure 1A 45 -# [006] 45 Fig. 2a 45 Oral Presentation # 45 wef #.#.# [002] 45 DEER Antlered 45 Cancer J Clin 45 OP# [001] 45 J Surg 45 Lnk 45 P# [002] 45 Clinical Outcome 45 Seq 45 Endocrinol 45 Section #AA [001] 45 NIST SP# 45 See TCA § 45 CFR Parts 45 #-#,# [007] 45 Winnipeg MB R2X 45 Np 45 #.#D [002] 45 #j [001] 45 Technical Specifications 45 Acta Paediatr 45 Otolaryngol Head Neck Surg 45 Kl 45 Orthop Surg 45 § #-#-# [002] 45 Slip Op 45 J Neurol 45 nse 45 #A #B [002] 45 Eur J Pharmacol 45 ps :# 45 Appellant Brief 45 J Biol 45 Nat Neurosci 45 DOI #.#/s#-#-#-# 45 WMUs 2C 2D 2E 45 Drug Discov 45 Contact Thea Lavin 45 M anagement 45 FAR #.#-# [003] 45 Old Woodstock Tn 45 pp. #-# [003] 45 B5 B6 45 Submittals 45 Clin Chem 45 LEXIS # [001] 45 Stmt 45 ISI Medline 45 Pti 45 Symptom Checklist 45 AnnuAl 45 s7 45 Fed.R.Civ.P. 45 Coleshill Utd 45 dtd 45 Compl 45 Badsey RBL 45 Dec# 0 45 Pearson correlation coefficient 45 CALJIC 45 J Neurosci 45 La Ce Pr 45 V/# 45 Polymerization 45 § § #-# [002] 45 deoxyglucose 45 J Foot Ankle 45 NJSA 2C 45 Act Cap. 45 Syndr 45 DOI #.#/j.cell.#.#.# 45 #:# -8 45 § § #.# [002] 45 See Appendix 45 Ordinance Cap. 45 CCITT 45 #.# Kenyan Shilling 45 Clevedon Dons 45 pte htdocs boxes 45 S#.# [006] 45 Diagn 45 #YR 45 Fig. 3b 45 E# [001] 45 Ultratrace 45 eme 45 Nurs 45 POL PRO 45 extn 45 Excitation 45 seq 45 Offeror Representations 45 :6 45 Arch Gen Psychiatry 45 Quay Bristol BS1 45 Psychiatry Clin Neurosci 45 Amending Directive 45 #,#-# [003] 45 -mother Arndrea 45 § #.# [003] 45 Nutrition Vol. 45 FNPRM 45 Reply Brief 45 J Physiol 45 # # [018] 45 LSA RS 45 SE4 45 G# [006] 45 Gov.Bar R. V 45 Doc. # 45 Pharmacother 45 Suppl S# [001] 45 e# e# [001] 45 PURSUANT TO SECTION 45 Vol. 45 Cardiovasc 45 B1 MM 44 #:#-# [040] 44 Subparagraph 44 Oph 44 annexin 44 Hysteresis 44 p SHP Rs.# 44 Crit Care Med 44 dpa jb 44 td tr 44 § #a [003] 44 Supplementary Fig 44 Vasc 44 J Clin Invest 44 See USSG § #A#.# 44 DEF STAN 44 interleukin IL 44 #-#-# [068] 44 Patty Schnyder SUI 44 CHMP Opinion 44 & gt 44 #:#-# [009] 44 § § #-# [001] 44 Prof. Code § 44 mu m 44 ANNEXURE 44 #A.# [003] 44 null mice 44 Practical Aspects 44 PMID # [001] 44 UNDER SECTION 44 § #-#-# b [001] 44 #-#-# [007] 44 Opn 44 Fiber Optic Connectors 44 Fed. Cl 44 TCA § 44 Measurement Uncertainty 44 Commn 44 Lvl 44 i#.rpm 44 TRUS 44 Epub ahead 44 #.#-# [020] 44 Macroscopic 44 Fv 44 Methodological 44 Immunol 44 CFR § § 44 Psychiatr 44 #:# -# [004] 44 UKHL 44 ÿÿ 44 Fig. 2d 44 Joshua Coppins NZL Yamaha 44 vol 44 Cts 44 S Nikkor #mm 44 twd ccg 44 # [003] 44 WDNY 44 § #.#-# [004] 44 www.thelancet.com 44 FAR #.# 44 See USSG § #B#.# 44 NMR Spectroscopy 44 #D #R 44 Pa.RAP 44 #T# #:# 44 ALGESTER 44 s.# [002] 44 ,4 44 wf 44 0Â 44 CONVERSION OF 44 CFR § #.# [001] 44 glucosidase 44 Nephrol Dial Transplant 44 #A #A [001] 44 J Am Acad 44 Article PubMed ISI ChemPort 44 Inj 44 CFR #.# [008] 44 Gg 44 CP#/# 44 H#.# 44 #U [005] 44 NJSA #:#-# [004] 44 L1A 44 #F #F [002] 44 auc 44 2a 2b 44 Clin Trials 44 Figure 3a 44 Genome Res 44 PTET 44 #-# CB 44 Schematic diagram 44 Enabling Clause 44 #.#A [004] 44 Hanney Utd 44 Nk 44 NCGS § #A 44 Platform openSUSE 44 dpa ds 44 1alpha 44 WELBECK 44 Ruhel date 44 ISBN #-#-#-#-# [002] 44 J Endocrinol 44 carboxylase 44 PO# [002] 44 Arch Dis Child 44 EN ISO # 44 d SPLC 44 Wkly 44 9L 44 Abbreviation 44 +#- 0 [001] 44 #E# [003] 44 Regulatory Regime 44 Arch Ophthalmol 44 Amdt 44 Hd 44 Optics Letters 44 Reverse Transcriptase 44 App'x 44 DUNS Number 44 Dynamical 44 2AB 44 Hong Kong Ministerial Declaration 44 Counterparty Criteria 44 #a [004] 44 section# 44 P.# [003] 44 NF Summary 44 Hr'g 44 A.2 44 nO 44 Noncritical 44 Res.# 44 #,#,#,# [011] 44 Fujitsu Siemens Computers PRIMEPOWER 44 USC § #A 44 0D 44 Compl. ¶ 44 Farrer Place 44 Floor Bangunan 44 trioxide 44 b# [003] 44 FCC Rcd 44 Cancer Epidemiol Biomarkers Prev 44 Miscellaneous Provisions 44 4N 44 wedge Hole TC# 44 No.#/# [004] 44 BMC Musculoskeletal Disorders 44 conta 44 Confirmatory 44 DCID 6 44 dpa nr 44 Supplemental Table 44 +5' 44 qq 44 affd 44 Susceptibility Testing 44 Eur Arch 44 Sh hd